Germitec

Bordeaux, France Founded: 2005 • Age: 21 yrs
UV-C disinfection systems for ultrasound probes are provided.

About Germitec

Germitec is a company based in Bordeaux (France) founded in 2005 by Clement Deshays. Germitec has raised $41.59 million across 2 funding rounds from investors including Eurazeo, Kurma Partners and Financiere Arbevel. Germitec offers products and services including Chronos, Antigermix, and Yuvee. Germitec operates in a competitive market with competitors including Butterfly Network, Exo, R-Zero, Zonare Medical Systems and SonoSite, among others.

  • Headquarter Bordeaux, France
  • Founders Clement Deshays
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website germitec.com/en-us
  • Social LinkedIn X Facebook
Key Metrics
  • Total Equity Funding
    $41.59M (USD)

    in 2 rounds

  • Latest Funding Round
    $30M (USD), Series B

    Feb 2025

  • Investors
    Eurazeo

    & 6 more

Products & Services of Germitec

Germitec offers a comprehensive portfolio of products and services, including Chronos, Antigermix, and Yuvee.

Chronos
Disinfection Device

Offers 90-second UV-C high-level disinfection for ultrasound probes.

Antigermix
Disinfection Device

Provides UV-C disinfection for long endocavitary probes in three minutes.

Yuvee
Disinfection Technology

Delivers UV-C based solutions to kill pathogens on medical devices.

Funding Insights of Germitec

Germitec has successfully raised a total of $41.59M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $41.59M
  • Total Rounds 2
  • Last Round Series B β€” $30M
  • First Round $11.59M

    (May 2022)

  • Investors Count 7

All 2 funding rounds of Germitec with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2025$30MSeries B–Eurazeo
May 2022$11.59MSeries B––
Valuation history

7 investors in total: 7 institutional.

Investors in Germitec

Germitec has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Eurazeo, Kurma Partners and Financiere Arbevel.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity and debt investments are managed across multiple sectors.
1969eurazeo.comParis, France
Biotech startups are funded through venture capital in life sciences.
2009kurmapartners.comParis, France
Private equity investments are made in companies across diverse sectors.
–turennecapital.comParis, France
Early to Growth stage VC & PE firm funding
–aquiti.frPessac, France
Galia Gestion is engaged in private equity investments in southwestern France.
–galia-gestion.comBordeaux, France
Investment management services are provided for clients in Paris.
1997arbevel.comParis, France
Offers insurance, risk management, and training for health and territorial entities.
1927sham.frLyon, France
Premium access

Investor details for Germitec

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Germitec

17 people are tracked at Germitec (9 in leadership, 5 in board & advisors, 3 in team).

NameRoleGroup
Clement Deshays
Founder & CEOLeadership
Rick Salzar
CEOLeadership
Vincent Gardes
CEOLeadership
Keith Koby
President North AmericaLeadership
Vincent Gardès
CEOLeadership
José Da Gloria
Deputy CEO & CFOLeadership
Pascale LAGRANGE
Quality & RA DirectorLeadership
Arnaud Casson
Chief Operations OfficerLeadership
Peggy Day-Dvorak
National And Government Accounts Sales DirectorLeadership
Bervin Bouani
Board MemberBoard & advisors
Jean-Francois Rivassou
Board MemberBoard & advisors
Louis Geslin
Board MemberBoard & advisors
Clément Deshays
ChairmanBoard & advisors
Patrice Taisson
Board MemberBoard & advisors
Claire Randolfi
Executive AssistantTeam
David Weller
Strategic Account Manager EastTeam
Victoria Potasz
Account ManagerTeam
Premium access

Complete people profiles for Germitec

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Germitec

3 dated milestones of Germitec across 20 years, from founding to its latest funding, stage changes and deals.

  1. Founded Germitec is founded.
  2. Funding First funding round of $11.6M.
  3. Funding Latest funding round, Series B, of $30.0M.

Competitors of Germitec

Germitec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Butterfly Network, Exo, R-Zero, Zonare Medical Systems and SonoSite, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
butterflynetwork.com2011Guilford, United States$350M225
Handheld ultrasound devices are developed for whole-body medical imaging.
exo.inc2015Redwood, United States$463.39M152
Ultrasound images are analyzed via AI-based software provided by Exo.
rzero.com2020San Francisco, United States$162.4M–
UV-C disinfection devices for hospital infection control are developed.
zonare.com1999Mountain View, United States$116.15M127
Portable ultrasound systems are developed and provided for medical use.
sonosite.com1986Bothell, United States–606
Hand-carried ultrasound systems for medical specialties are developed and distributed.
baylabs.io2013San Francisco, United States$16.15M65
Deep learning-based imaging diagnostics for heart diseases are developed.
cisuvc.com1997Albany, United States$15.23M–
Ultraviolet light-emitting diodes are provided using aluminum nitride technology.
techsomed.com2012Rehovot, Israel$9.6M–
Ultrasound-based monitoring systems for thermal ablation procedures are developed.
Premium access

Detailed competitors of Germitec

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Germitec

The website of Germitec (germitec.com) receives about 1.5K visits a month.

  • Monthly visits
    1.5K

    ▼ 39.4% vs previous month

Similar websites

Websites whose visitors overlap most with Germitec. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
google.fr
google.fr
100%
–#273–

Latest news on Germitec

Premium access

Complete news archive for Germitec

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Germitec

10 companies that operate in the same segment as Germitec (Imaging Diagnostics), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Handheld ultrasound devices are developed for whole-body medical imaging.
2011Guilford, Connecticut, United StatesUSD 350 MUSD 97.61 M190
Technology tools and systems for molecular scale are developed.
1959Abingdon, Oxfordshire, United Kingdom–USD 648.1 M–
Robotic microsurgical systems for endoscopy are developed.
2007Redwood City, California, United StatesUSD 733.17 M–242
Manufacturer of imaging and surgical products
1919Tokyo, Tokyo, Japan–USD 6.49 B35,933
Ultrasound images are analyzed via AI-based software provided by Exo.
2015Redwood City, California, United StatesUSD 463.39 M––
Planar X-ray radiology products for diagnostic imaging are supplied.
2000Oxford, Oxfordshire, United KingdomUSD 43.43 MUSD 1.04 M50
Digital X-ray sources are developed by Nanox for cloud-based diagnostics.
2004Jerusalem, Jerusalem District, IsraelUSD 110.72 MUSD 13.02 M165
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
2007Los Angeles, California, United StatesUSD 59.64 M––
Portable wireless ultrasound systems are developed for medical imaging.
2014Burnaby, British Columbia, CanadaUSD 21.87 M––
Portable MRI systems are manufactured for medical professionals.
2014New York, New York, United States–USD 13.56 M111
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Germitec

Germitec was founded in 2005 and raised its 1st funding round 17 years after it was founded.

Germitec is headquartered in Bordeaux, France.

Clement Deshays is the current CEO of Germitec. They have also founded this company.

Germitec is a funded company, having raised a total of $41.59M across 2 funding rounds to date. The company's 1st funding round was a Series B of $11.59M, raised on May 2022.

Germitec was founded in 2005 in Bordeaux, France, and operates in the medical device sector. UV-C light-based systems for high-level disinfection of endocavitary and external ultrasound probes are developed and supplied. Pathogens including bacteria, fungi, viruses, mycobacteria, and spores are targeted by the technology. Workflow optimization and traceability features are incorporated into the systems. A chemical-free method is employed to support healthcare operations across Europe and beyond.

Germitec's top competitors include Butterfly Network, Exo and R-Zero.

Germitec offers Chronos, Antigermix, and Yuvee.

Germitec has 7 investors. Key investors include Eurazeo, Kurma Partners, Financiere Arbevel, Turenne Groupe, and Sham.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available